GeneNews (GEN) Stock Price, News & Analysis

Company Overview

Generation Uranium is a Canadian resource exploration company with a focus on Uranium. The Company is advancing its 100-per-cent-owned Yath uranium project, strategically located in Nunavut's Angilak district, one of Canada's most active emerging uranium camps. With a robust pipeline of high-priority exploration targets and exposure to proven uranium-bearing corridors, Generation is well positioned to contribute to the future supply of clean nuclear energy.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 473,147 shs
• Average Volume: 1.48 million shs
• Market Capitalization: C$25.49 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: TSE:GEN
• CIK: N/A
• Web: www.genenews.com
• Phone: +1-905-7392030
• Fax: N/A
• Employees: 2,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.10
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: C$234.59 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 145.00
• Book Value: C($0.06) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 169,963,000
• Free Float: N/A
• Market Cap: C$25.49 million
• Optionable: Not Optionable
• Beta: N/A